NEW YORK (TheStreet) -- CHANGE IN RATINGS
Alaska Air was upgraded at Morgan Stanley to equal-weight based on improved fiscal-year 2013-2014 estimates. Company's high relative margin strength has potential to generate cash returns, Morgan Stanley said. Price target was raised to $65.
Alpha Natural was upgraded at Deutsche Bank to buy from hold. $7.50 price target. There is room for improvement in the coking coal market, Deutsche Bank said.
Bristol-Myers was downgraded at Jefferies to hold from buy. Valuation call, based on a $49 price target, Jefferies said.
Quest Diagnostics was initiated with a neutral rating at Robert Baird. $58 price target. Turnaround story may still take some time, Robert Baird said.
Discovery was downgraded to neutral from buy at B. Riley. Valuation call, as the stock is up 33% year to date, B. Riley said.
Eaton was initiated with a buy rating at Argus Research. $78 price target. Company should benefit from secular infrastructure growth trends, Argus said.
FedEx was initiated with a buy rating at Wunderlich. $120 price target. Company should benefit from favorable long-term secular trends, Wunderlich said.
F5 Networks was upgraded at Piper Jaffray to overweight from neutral. $88 price target. Company can execute better and deliver better product growth, Piper Jaffray said.
Hormel was upgraded at BMO Capital to outperform from market perform. $49 price target. Company has multiple potential earnings levers, BMO Capital said.
Kroger was downgraded at Goldman Sachs to sell from neutral despite increased $35 price target, Goldman Sachs said. The best-in-class grocer now trades at a premium as the market has priced-in KR's price and position advantages, Goldman said.
LPL Financial was upgraded to buy at TheStreet Ratings.
NewStar Financial was upgraded to buy at TheStreet Ratings.
Pfizer was downgraded at Jefferies to hold from buy. Valuation call, based on a $30 price target, Jefferies said.
Quality Systems was upgraded at Robert Baird to outperform from neutral. $26 price target. Company has the lowest valuation in the sector but should see improved themes and bookings in the near future, Robert Baird said.
Regeneron was upgraded at Lazard Capital Markets to buy and given a new $298 price target. Growth potential in multiple business lines, said Lazard Capital Markets. The company is positioned to reap large sums of cash from its drug Eylea and a new class of biologics, Lazard Capital Markets also said.
Sprint was downgraded at J.P. Morgan to neutral and given a new $7 price target. Changes were based on share price/valuation discrepancies, J.P. Morgan said. Company will likely become price-competitive and generate profits in the future but is scheduled for infrastructure and local-marketing development in the near term, J.P. Morgan said.
Sodastream was downgraded at Oppenheimer to perform from outperform. Company could post choppy second-quarter results, Oppenheimer said.
Target was downgraded at Deutsche Bank to hold from buy. Valuation call, based on a $74 price target, Deutsche Bank said.
Texas Roadhouse was downgraded at BMO Capital to market perform. Valuation call, as the stock is up 50% year to date, BMO Capital said.
Wendy's was upgraded at BMO Capital to outperform. $7 price target. Company is an attractive, long-term turnaround story, BMO Capital said.
Xilinx was upgraded at Citigroup to buy and given a new $50 price target. Changes were based on higher 2014 estimates, Citigroup said. The company is poised for above-industry growth driven by Chinese wireless infrastructure development, Citi said.
Yelp was initiated with a buy rating at Needham. Company can continue to deliver growth in the coming years, Needham said.
STOCK COMMENTS/EPS CHANGES
Gap estimates, price target were raised at Sterne Agee. Shares are now seen reaching $40. Estimates were also increased, given solid comp sales growth, Sterne Agee said. Underperform rating.
Johnson Controls was added to Priority Stock List at Wells Fargo. Stock has underperformed since May, but the new CEO can turn things around, Wells Fargo said.
>To submit a news tip, email: email@example.com.
Follow TheStreet on Twitter and become a fan on Facebook.
EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
- Investment & Company Information
- Deutsche Bank
- Morgan Stanley
- Lazard Capital Markets